MIXED DYSLIPIDEMIA
Clinical trials for MIXED DYSLIPIDEMIA explained in plain language.
Never miss a new study
Get alerted when new MIXED DYSLIPIDEMIA trials appear
Sign up with your email to follow new studies for MIXED DYSLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple therapy aims to melt artery plaque before first heart attack
Disease control Not yet recruitingThis study tests whether a combination of three cholesterol-lowering medicines (bempedoic acid, ezetimibe, and a high-intensity statin) can reduce and stabilize plaque buildup in the coronary arteries. It includes 103 adults with early atherosclerosis who have never had a heart a…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE3 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New cholesterol drug put to the test in healthy volunteers
Disease control Not yet recruitingThis early-stage study tests a new drug for mixed dyslipidemia (high cholesterol and fats in the blood) in 60 healthy adults. Participants will receive two versions of the drug at different times to compare how the body absorbs and processes them. The goal is to gather safety and…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE1 • Sponsor: Addpharma Inc. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New Omega-3 pill aims to boost heart health in people with imbalanced blood fats
Disease control Not yet recruitingThis study tests if a new type of omega-3 supplement (Ruby-O) can improve the Omega-3 Index—a blood marker of heart health—better than standard omega-3 in adults with mixed dyslipidemia (imbalanced blood fats). About 105 participants on stable statin therapy will take one of two …
Matched conditions: MIXED DYSLIPIDEMIA
Phase: NA • Sponsor: Fundación del Caribe para la Investigación Biomédica • Aim: Disease control
Last updated May 14, 2026 12:02 UTC